ANX-042

N/A

Report date: 2023/02/25 19:25:13
NME

Base Information

Drug NameANX-042
Drug Alias NameASBNP.1ANX-042
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNatriuretic peptides stimulants
TargetsNatriuretic peptides
Therapy Area/IndicationsHeart FailureCardio-Renal SyndromeRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo ClinicAnexon Inc
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesAnexon Inc
Active IndicationsHeart FailureCardio-Renal SyndromeRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A